Global Endorectal Balloon Market to Showcase Vigorous Demand during the Period u
Posted by Arslan on December 20th, 2018
The increasing use of an endorectal balloon in the healthcare sector is fueled by the advantages provided by the endorectal balloon for better inflation and deflation control and greater visibility. The Endorectal Balloon Market is therefore subjected to witness overwhelming growth owing to the need for providing improved clinical assistance for patients and the growing application of medical devices to ease the process of treatments and cater to the need of radiotherapy.
As the endorectal balloon application includes numerous advantages which include stabilizing the prostate gland and rectum during daily treatment, major market players such as Bionix and QLRAD are focusing on introducing an improved endorectal balloon for providing ease to patients while they undergo treatments, helping them gain a competitive edge with greater accuracy and enhanced simplicity. Furthermore, the medical device manufacturers today are seen collaborating and getting involved in strategic partnerships for the effective commercialization of their next-generation products which includes the endorectal balloon exclusively for radiotherapy and prostate cancer treatment. These developments are expected to nurture the endorectal balloon market with changing clinical requirements.
The endorectal balloon is single-use, inflatable, disposable, non-powered rectal device used in immobilization of prostate in patients. These devices are intended to be used in patients undergoing radiotherapy and it can be used in all stages. The endorectal balloon is traditionally used in the treatment of prostate cancer with benefits like consistent rectal filing & prostate stability. The endorectal balloon is used to move posterior wall away from the prostate and helps in reduction of radiation to the rectum and mucosal wall. It can be well tolerated in over 95% of patients. While, they are contraindicated in patients with severe hemorrhoids, anal fissures, peri-rectal/peri-anal abscess, rectal fistula, anal canal stricture and prior low anterior resection. When it comes to technical information, endorectal balloon contains two radiopaque markers and they are located in the catheter shaft. It is equipped with a valve and it controls inflation and deflation. Advantages of the endorectal balloon include infra-fraction motion control, limit radiation dose to the wall, controls late toxicity, increases visibility and increases patient compliance.
Increasing demand for intensity modulated radiotherapy by decreasing toxicity of rectum accelerates the growth of endorectal balloon market. Prostate infraction motion is the major concern in radiotherapy, regardless of the type of therapy. Typically, prostate motion is associated with rectal fillings and bladder function. Along with this, advancement of technologies enabled usage of proton therapy for prostate cancer treatment. It allows dose distribution to the target area and controls the dose escalation. But, dose escalation of a dose is also associated with toxicities. To avoid dose escalations in proton therapies, the endorectal balloon is used to control the dose escalations, prostate movement and increases the rectal filling without disturbing normal physiological functions.
To know more about the Endorectal Balloon Market Visit the link- https://www.factmr.com/report/871/endorectal-balloon-market
The endorectal balloon is used to improve the target localization, decreases anorectal toxicities. Emerging evidence of endorectal balloon advantages in reducing toxicities are expected to boost the growth of the market. All these factors fueled the burgeoning growth of endorectal balloon market. Further, the advantages of the endorectal balloon over the conventional methods accelerated the growth of the market.
The lack of substantial evidence regarding the benefits of the endorectal balloon in the large patient pool has limited the growth of endorectal balloon market.
Global Endorectal Balloon market has witnessed a robust growth due to increasing demand for devices. They are more advantageous over conventional methods in treating prostate cancer. It controls dose escalations and reduces the rectum toxicity. Endorectal Balloon market has a presence of a few players which have a huge market share in the global market operating at the country level. There are huge opportunities for the untapped markets across the world due to potential benefits of Endorectal Balloon. The key players in the Endorectal Balloon market are mainly focused on R&D to accelerate the development due to a limited number of manufactures. The future of Endorectal Balloon market anticipated with double CAGR during forecasting period.
Global endorectal balloon market is segmented into the following regions - North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and the Middle East & Africa. North America is dominant in the global endorectal balloon market mainly due to the increasing prevalence of prostate cancer. In North America, particularly the USA is dominating due to high adoption among end users. Economic conditions in the APAC region are set to drive the endorectal balloon market to new heights. Europe and APAC endorectal balloon markets are fastest growing regions due to increasing awareness. Growth in the Middle East and African region is considerably less when compared to the other regions. However, North America would maintain its position in the endorectal balloon market, though, we are anticipating developed economies such as Australia to have the highest growth rate in the endorectal balloon market.
The key participants in Endorectal Balloon Market are QLRAD, Bionix, and others. The companies are mainly focusing on collaborations and partnerships to keep up the pace of the competition and to develop new products.
Like it? Share it!
About the AuthorArslan
Joined: December 18th, 2017
Articles Posted: 13,297
More by this author